These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 25998535)

  • 1. How do we estimate survival? External validation of a tool for survival estimation in patients with metastatic bone disease-decision analysis and comparison of three international patient populations.
    Piccioli A; Spinelli MS; Forsberg JA; Wedin R; Healey JH; Ippolito V; Daolio PA; Ruggieri P; Maccauro G; Gasbarrini A; Biagini R; Piana R; Fazioli F; Luzzati A; Di Martino A; Nicolosi F; Camnasio F; Rosa MA; Campanacci DA; Denaro V; Capanna R
    BMC Cancer; 2015 May; 15():424. PubMed ID: 25998535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can We Estimate Short- and Intermediate-term Survival in Patients Undergoing Surgery for Metastatic Bone Disease?
    Forsberg JA; Wedin R; Boland PJ; Healey JH
    Clin Orthop Relat Res; 2017 Apr; 475(4):1252-1261. PubMed ID: 27909972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can A Multivariate Model for Survival Estimation in Skeletal Metastases (PATHFx) Be Externally Validated Using Japanese Patients?
    Ogura K; Gokita T; Shinoda Y; Kawano H; Takagi T; Ae K; Kawai A; Wedin R; Forsberg JA
    Clin Orthop Relat Res; 2017 Sep; 475(9):2263-2270. PubMed ID: 28560532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. External Validation of PATHFx Version 3.0 in Patients Treated Surgically and Nonsurgically for Symptomatic Skeletal Metastases.
    Anderson AB; Wedin R; Fabbri N; Boland P; Healey J; Forsberg JA
    Clin Orthop Relat Res; 2020 Apr; 478(4):808-818. PubMed ID: 32195761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. External validation of the Bayesian Estimated Tools for Survival (BETS) models in patients with surgically treated skeletal metastases.
    Forsberg JA; Wedin R; Bauer HC; Hansen BH; Laitinen M; Trovik CS; Keller JØ; Boland PJ; Healey JH
    BMC Cancer; 2012 Oct; 12():493. PubMed ID: 23098538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of PATHFx 2.0: An open-source tool for estimating survival in patients undergoing pathologic fracture fixation.
    Overmann AL; Clark DM; Tsagkozis P; Wedin R; Forsberg JA
    J Orthop Res; 2020 Oct; 38(10):2149-2156. PubMed ID: 32492213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. External Validation and Optimization of the SPRING Model for Prediction of Survival After Surgical Treatment of Bone Metastases of the Extremities.
    Sørensen MS; Gerds TA; Hindsø K; Petersen MM
    Clin Orthop Relat Res; 2018 Aug; 476(8):1591-1599. PubMed ID: 30020148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimating survival in patients with operable skeletal metastases: an application of a bayesian belief network.
    Forsberg JA; Eberhardt J; Boland PJ; Wedin R; Healey JH
    PLoS One; 2011; 6(5):e19956. PubMed ID: 21603644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Machine learning algorithms to estimate 10-Year survival in patients with bone metastases due to prostate cancer: toward a disease-specific survival estimation tool.
    Anderson AB; Grazal C; Wedin R; Kuo C; Chen Y; Christensen BR; Cullen J; Forsberg JA
    BMC Cancer; 2022 Apr; 22(1):476. PubMed ID: 35490227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. External validation of the PATHFx decision-support tool on Turkish patients with skeletal metastasis.
    Ozkan K; Ozturan B; Karadag Z; Erol B; Alpan B; Ozger H; Gurkan V; Sofulu O; Yalcinkaya M; Okay E; Forsberg JA
    Indian J Cancer; 2023 Feb; ():. PubMed ID: 36861722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can a Bayesian belief network for survival prediction in patients with extremity metastases (PATHFx) be externally validated in an Asian cohort of 356 surgically treated patients?
    Hsieh HC; Lai YH; Lee CC; Yen HK; Tseng TE; Yang JJ; Ling SY; Hu MH; Hou CH; Yang RS; Wedin R; Forsberg JA; Lin WH
    Acta Orthop; 2022 Sep; 93():721-731. PubMed ID: 36083697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical decision support and individualized prediction of survival in colon cancer: bayesian belief network model.
    Stojadinovic A; Bilchik A; Smith D; Eberhardt JS; Ward EB; Nissan A; Johnson EK; Protic M; Peoples GE; Avital I; Steele SR
    Ann Surg Oncol; 2013 Jan; 20(1):161-74. PubMed ID: 22899001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treating metastatic disease: Which survival model is best suited for the clinic?
    Forsberg JA; Sjoberg D; Chen QR; Vickers A; Healey JH
    Clin Orthop Relat Res; 2013 Mar; 471(3):843-50. PubMed ID: 22983682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting survival of patients with spinal metastatic disease using PathFx 3.0 - A validation study of 668 patients in Sweden.
    Carrwik C; Tsagkozis P; Wedin R; Robinson Y
    Brain Spine; 2022; 2():101669. PubMed ID: 36506283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of IMPACT, CRASH and Nijmegen models in predicting six month outcome of patients with severe or moderate TBI: an external validation study.
    Majdan M; Lingsma HF; Nieboer D; Mauritz W; Rusnak M; Steyerberg EW
    Scand J Trauma Resusc Emerg Med; 2014 Nov; 22():68. PubMed ID: 25406964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of survival after surgical management of femoral metastatic bone disease - A comparison of prognostic models.
    Meares C; Badran A; Dewar D
    J Bone Oncol; 2019 Apr; 15():100225. PubMed ID: 30847272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. External Validation of a Score Predictive of Recurrence after Radical Surgery for Non-Cardia Gastric Cancer: Results of a Follow-Up Study.
    Marrelli D; Morgagni P; de Manzoni G; Marchet A; Baiocchi GL; Giacopuzzi S; Coniglio A; Mocellin S; Saragoni L; Roviello F;
    J Am Coll Surg; 2015 Aug; 221(2):280-90. PubMed ID: 26141465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Comprehensive Risk Assessment for Bypass (CRAB) facilitates efficient perioperative risk assessment for patients with critical limb ischemia.
    Meltzer AJ; Graham A; Connolly PH; Meltzer EC; Karwowski JK; Bush HL; Schneider DB
    J Vasc Surg; 2013 May; 57(5):1186-95. PubMed ID: 23375435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An easy tool to predict survival in patients receiving radiation therapy for painful bone metastases.
    Westhoff PG; de Graeff A; Monninkhof EM; Bollen L; Dijkstra SP; van der Steen-Banasik EM; van Vulpen M; Leer JW; Marijnen CA; van der Linden YM;
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):739-47. PubMed ID: 25260489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. International multicenter tool to predict the risk of nonsentinel node metastases in breast cancer.
    Meretoja TJ; Leidenius MH; Heikkilä PS; Boross G; Sejben I; Regitnig P; Luschin-Ebengreuth G; Žgajnar J; Perhavec A; Gazic B; Lázár G; Takács T; Vörös A; Saidan ZA; Nadeem RM; Castellano I; Sapino A; Bianchi S; Vezzosi V; Barranger E; Lousquy R; Arisio R; Foschini MP; Imoto S; Kamma H; Tvedskov TF; Kroman N; Jensen MB; Audisio RA; Cserni G
    J Natl Cancer Inst; 2012 Dec; 104(24):1888-96. PubMed ID: 23117131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.